Samsara BioCapital as of Dec. 31, 2018
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 17 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allakos (ALLK) | 23.0 | $24M | 458k | 52.27 | |
| Intercept Pharmaceuticals In | 22.7 | $24M | 234k | 100.79 | |
| Principia Biopharma | 10.1 | $11M | 384k | 27.39 | |
| Sutro Biopharma (STRO) | 9.8 | $10M | 1.1M | 9.02 | |
| Odonate Therapeutics Ord | 8.1 | $8.4M | 596k | 14.08 | |
| Liquidia Technologies (LQDA) | 7.9 | $8.2M | 378k | 21.66 | |
| Syros Pharmaceuticals | 5.7 | $5.9M | 1.1M | 5.57 | |
| Kalvista Pharmaceuticals (KALV) | 2.8 | $3.0M | 150k | 19.75 | |
| Evelo Biosciences | 2.8 | $3.0M | 228k | 13.01 | |
| Miragen Therapeutics | 2.6 | $2.8M | 909k | 3.03 | |
| Aravive | 1.5 | $1.6M | 443k | 3.52 | |
| Catabasis Pharmaceuticals Ord | 1.3 | $1.3M | 300k | 4.37 | |
| Urovant Sciences | 1.0 | $1.0M | 158k | 6.59 | |
| Millendo Therapeutics | 0.3 | $359k | 45k | 7.96 | |
| Surface Oncology | 0.3 | $332k | 78k | 4.24 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $122k | 72k | 1.70 | |
| Edge Therapeutics | 0.1 | $59k | 183k | 0.32 |
